DARE vs NCEL
Comparison between Dare Bioscience Inc (DARE, Company) and NLS Pharmaceutics Ltd (NCEL, Company).
Both DARE and NCEL are from the Healthcare sector.
5-Year PerformanceDARE has outperformed NCEL, delivering a return of -41.7% compared to -68.2%
DARE vs NCEL - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DARE vs NCEL - Historical Returns
Returns include dividend reinvestment.
DARE vs NCEL - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | DARE | NCEL |
|---|---|---|
| 2026 | -36.41% | +60.83% |
| 2025 | -40.06% | -91.28% |
| 2024 | -20.95% | -91.03% |
| 2023 | -64.38% | -57.86% |
| 2022 | -60.29% | +8.40% |
| 2021 | +52.67% | -61.59% |
| 2020 | +63.41% | N/A |
| 2019 | +11.14% | N/A |
| 2018 | -68.56% | N/A |
| 2017 | -71.90% | N/A |
| 2016 | -76.70% | N/A |
| 2015 | -56.39% | N/A |
| 2014 | -9.20% | N/A |
DARE vs NCEL Drawdown Comparison
The maximum drawdown for DARE was -99.91%, occurring on Jul 29, 2026. This drawdown has not yet recovered.
The maximum drawdown for NCEL was -99.92%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current DARE drawdown is -99.90%. The current NCEL drawdown is -99.86%.
| Rank | DARE | NCEL |
|---|---|---|
| #1 | -99.91% Mar 19, 2015 - Jul 29, 2026 | -99.92% Mar 12, 2021 - Mar 30, 2026 |
| #2 | -52.54% Jun 19, 2014 - Jan 7, 2015 | -35.41% Feb 11, 2021 - Mar 12, 2021 |
| #3 | -27.52% Jan 23, 2015 - Mar 18, 2015 | -9.34% Jan 29, 2021 - Feb 3, 2021 |
| #4 | -23.52% Apr 22, 2014 - Jun 18, 2014 | -7.69% Feb 4, 2021 - Feb 11, 2021 |
| #5 | -7.09% Apr 14, 2014 - Apr 22, 2014 | N/A |
| #6 | -5.25% Jan 12, 2015 - Jan 23, 2015 | N/A |
| #7 | -3.34% Jan 8, 2015 - Jan 12, 2015 | N/A |
Correlation
Correlation between DARE and NCEL is 0.84 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks